Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21670735 | 0.83 | LTA4H (0.38) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL1637997 | 0.77 | MEN1 (0.44) | L3MBTL1MEN1KMT2APOLBMAPT | |
| SCHEMBL17519104 | 0.77 | MAPT (0.42) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL17519113 | 0.77 | LTA4H (0.37) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL17519094 | 0.77 | LTA4H (0.37) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL1105198 | 0.77 | KMT2A (0.45) | LTA4HMEN1KMT2APOLBUSP2 | |
| SCHEMBL14435203 | 0.76 | MEN1 (0.42) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL6511981 | 0.76 | MEN1 (0.42) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL13132269 | 0.76 | MEN1 (0.42) | L3MBTL1LTA4HMEN1KMT2APOLB | |
| SCHEMBL16340365 | 0.76 | ANPEP (0.38) | L3MBTL1MEN1KMT2APOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7468399-B2 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-23 | — | — | US | claimed |
| EP-1634928-B1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHINETSU CHEMICAL CO (JP) | 2007-10-31 | — | — | EP | claimed |
| EP-3892701-B1 | UV CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHINETSU CHEMICAL CO (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20250287559-A1 | MICROSTRUCTURE-TRANSFER APPARATUS, STAMP HEAD UNIT, STAMP COMPONENT FOR TRANSFERRING MICROSTRUCTURE, AND METHOD FOR TRANSFERRING MICROSTRUCTURE-INTEGRATED COMPONENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12342467-B2 | Microstructure-transfer apparatus, stamp head unit, stamp component for transferring microstructure, and method for transferring microstructure-integrated component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-24 | — | — | US | disclosed |
| US-12168745-B2 | Ultraviolet ray curable silicone adhesive composition and cured product thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-12-17 | — | — | US | disclosed |
| EP-3885420-B1 | ULTRAVIOLET RAY CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHINETSU CHEMICAL CO (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-20230348758-A1 | ADDITION-CURING SILICONE PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND CURED OBJECT OBTAINED THEREFROM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230242544-A1 | QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2023-08-03 | — | — | US | disclosed |
| EP-4209563-A1 | ULTRAVIOLET RAY CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-12 | — | — | EP | disclosed |
| EP-4101905-A1 | ADDITION-CURING SILICONE PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND CURED OBJECT OBTAINED THEREFROM | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-12-14 | — | — | EP | disclosed |
| EP-3885420-A1 | ULTRAVIOLET RAY CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-09-29 | — | — | EP | disclosed |
| CN-113166626-A | Ultraviolet-curable silicone pressure-sensitive adhesive composition and cured product thereof | 信越化学工业株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-113039254-A | Ultraviolet-curable silicone pressure-sensitive adhesive composition and cured product thereof | 信越化学工业株式会社 | 2021-06-25 | — | — | CN | disclosed |
| WO-2021039128-A1 | METHOD FOR TRANSFERRING MICROSTRUCTURES, AND METHOD FOR MOUNTING MICROSTRUCTURES | 信越化学工業株式会社 | 2021-03-04 | — | — | WO | disclosed |
| WO-2020116126-A1 | UV CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | 信越化学工業株式会社 | 2020-06-11 | — | — | WO | disclosed |
| US-7468399-B2 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-23 | — | — | US | disclosed |
| EP-1634928-B1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHINETSU CHEMICAL CO (JP) | 2007-10-31 | — | — | EP | disclosed |
| US-20060058452-A1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. | 2006-03-16 | — | — | US | disclosed |
| EP-1634928-A1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242544-A1 | QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF | KRAS, NRAS, HRAS | L3MBTL1 4725/4885LMNA 3720/4885LTA4H 4321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.